Breakthroughs in Healthcare Diversity Symposium: Creating Patient, Clinician, & Technology Networks
What Are the Challenges of Delivering Healthcare to Underserved Patient Groups?
San Francisco, CA, USA
San Francisco, CA, USA
The Breakthroughs in Healthcare Diversity Symposium is a leading collaborative symposium for patients, patient groups, clinicians, researchers, technologists, healthcare and life science executives, and diversity and inclusion advocates to discuss diversity and inclusion in healthcare. The symposium brings these groups together in a collaborative forum to create networks, discuss best practices, and exchange new ideas related to making healthcare more diverse, with a specific focus on understanding how to serve underserved patient groups, including racial and ethnic minorities, women, and the LGBT community. The symposium will also focus on in helping provider, pharma, and other organizations who serve patients with the latest ideas and insights on how these organizations can become more diverse and inclusive in order to best understand the unique and diverse needs of the patients they serve. Attendees will learn the newest insights and ideas, discuss practical solutions, and meet industry and marketplace colleagues.
a leading educational symposium on patient-centered health outcomes and diversity in the treatment of diverse patient populations that include the LGBT community, women, racial and ethnic minorities, and individuals of low socioeconomic status
new knowledge and ideas on the crucial role technology plays in making healthcare more diverse and how technology firms are innovating healthcare delivery
best practices for recruiting, retaining, and promoting a diverse workforce, from entry-level to C-Suite and boardrooms
how diversity and inclusion drive innovation within organizations
cross-sectorial and multi-industry collaboration and innovation by connecting key partners in industry, patient groups, providers, and academia
and share ideas with many of the country’s leading life science and healthcare professionals who are passionate about diversity and inclusion
on building an organizational culture that attracts the best and brightest people, resulting in a diverse workforce where all ideas are valued
the obstacles to clinical trials, comparative effectiveness research, and healthcare access for underrepresented patient populations
Ricki Fairley is the Founder, President and Thought Leader of DOVE Marketing, a marketing agency with a mission to deliver iconic thinking, strategic problem solving and creative genius to clients seeking profitable business results. Fairley is a seasoned marketer with over 30 years of marketing experience including 20 years in brand management at Johnson & Johnson, Nabisco, Reckitt & Colman and The Coca-Cola Company, and over ten years in agency leadership encompassing strategic planning and consulting for numerous Fortune 500 companies. She is passionate about helping clients identify marketplace opportunities, establish insight-based objectives and strategies, and build results-driven campaigns with resonating creative. Ricki holds the Leadership Award from the Creative Thinking Association of America, and was named a Top 100 Marketer by Black Enterprise Magazine in February 2011. In November 2013, Ricki received the Association of National Advertisers Multicultural Excellence Award for the African American advertising for the Obama for America campaign. In February 2014, Ricki was inducted into The HistoryMakers. In March 2014, she received the Game Changer Award from Café Mocha and the Atlanta Tribune. In May 2014, DOVE Marketing received the US Trade & Commerce Institute Excellence in Marketing Award. Ricki was featured as Chapter 8 in “The 50 Billion Dollar Boss,” New York Times Best Seller List 2016 for Best Business books.
Ricki holds a BA from Dartmouth College and an MBA from Kellogg School of Management at Northwestern University. She is the President Emeritus of the Black Alumni of Dartmouth Association, and serves on the board of Kenny Leon’s True Colors Theatre Company. Ricki is Chair of the Board of Trustees and chairs the Marketing Committee for the Triple Negative Breast Cancer Foundation and works diligently to garner publicity for breast cancer awareness. As a Stage 3A Triple Negative Breast Cancer Survivor/Thriver, she speaks regularly to advocate for awareness of the disease. She is also a member of the 2011 Class of Leadership Atlanta.
Dr. Todd Strumwasser, MD, is the Senior Vice President, Operations at Dignity Health. He is responsible for the Bay Area Service Area and an assigned portfolio of healthcare assets which includes acute care, ambulatory outpatient services, philanthropy, physician alignment and employment business models, as well as other alternative healthcare delivery systems. Prior to joining Dignity Health, Dr. Todd Strumwasser served as the Chief Executive of two hospitals in Seattle’s Swedish Health Services system, Swedish First Hill and Swedish Cherry Hill. Dr. Strumwasser graduated from the University of California, Davis, and received his M.D. from the University of Southern California. He completed a residency in anesthesiology from the University of Washington Affiliated Hospitals, where he served as chief resident. He completed a certificate in executive development at the University of Washington, Keck School of Business.
Dr. Arturo Molina, MD, MS, is the Chief Medical Officer at Sutro Biopharma. Dr. Arturo Molina, an oncologist, has led scientific innovation and driven clinical programs forward for over twenty years. With his extensive experience interacting with the FDA and other global regulatory bodies, he has led the development of hematological and oncologic clinical candidates from phase I through phase III and through post-marking trials. He joins Sutro from his former role as VP of oncology and scientific innovation at Johnson & Johnson’s California Innovation Center where he was involved in the evaluation of novel biologics and small molecules, with a focus on immuno-oncology. While working for Johnson & Johnson, Dr. Molina oversaw the approval of Zytiga® in a multitude of countries for metastatic castration resistant prostate cancer indications. Previously, Dr. Molina served as chief medical officer and executive vice-president of Cougar Biotechnology where his leadership efforts advanced the company’s abiraterone program, Zytiga®, from phase I into several global phase III studies. He played a substantial role in the diligence efforts which led to the near $1B acquisition of Cougar by Johnson & Johnson. Dr. Molina has also held leadership positions at Biogen Idec where he led the hematology/oncology clinical development team and oversaw the post-approval label expansion of Rituxan® in front-line follicular lymphoma and diffuse large B-cell lymphoma (DLBCL). Dr. Molina was a faculty staff physician and adjunct professor in hematology/bone marrow transplantation and medical oncology/therapeutics research at the City of Hope Comprehensive Cancer Center. Dr. Molina received his M.D. and M.S. degrees from Stanford University School of Medicine in Stanford, CA. He is board certified in internal medicine and medical oncology and has an active California medical license. He additionally has earned distinction as a Fellow of the American College of Physicians.
Dr. Joshua Newman, MD, MSHS, is Chief Medical Officer at Salesforce. Dr. Newman has a 15-year history in Health IT, having designed, built, and managed web applications that have been used to digitalize medical residency administration, billing, and clinical care, to promote collaboration between physicians, and to ease the adoption of electronic medical records systems. In his current role at Salesforce, he leads the strategy and cross-functional efforts on the company’s health products, develops partner and customer presence on the Salesforce development platform, and enables health applications for non-profit organizations through the Salesforce Foundation. Prior to Salesforce, he worked as a practicing physician and Assistant Clinical Professor of Medicine at UCLA with a research focus on health information technology. Dr. Newman received his MD from the University of Illinois at Chicago, and completed his residency in Family Medicine at the Advocate Illinois Masonic/UIC program. He completed a Robert Wood Johnson Clinical Scholars Program, a postgraduate fellowship at UCLA, and received an MSHS degree in Health Services. He is a member of a number of professional organizations around medicine and technology.
The Kaleidoscope Group
Mr. Doug Harris is the Chief Executive Officer of The Kaleidoscope Group with almost 30 years of experience in the field of diversity & inclusion consulting. Prior to joining Bea Young Associates in 1993, Doug worked for several years as a consultant and trainer for Harbridge House, Inc. where he facilitated diversity & inclusion education sessions with senior executives of Fortune 500 organizations. Today, as the leader of The Kaleidoscope Group, Doug empowers organizations to achieve their diversity and inclusion goals. His knowledge and expertise guides organizations through the creation of customized strategies that address the specific diversity needs of the business. He recently developed and launched The Kaleidoscope Group Youth Practice to assist underserved youth in the Chicagoland and surrounding communities and is working with Tufts University to design and implement a student leadership development program.
Center for Healthcare Innovation
Mr. Joseph Gaspero is the CEO and Co-Founder of CHI. He is a healthcare executive, strategist, and researcher. Joseph leads CHI’s research and education initiatives focusing on including patient-driven healthcare, patient engagement, clinical trials, drug pricing, and other pressing healthcare issues. He sets and executes CHI’s strategy, devises marketing tactics, leads fundraising efforts, and manages CHI’s Management team. His leadership stems from a wide array of experiences, including founding and operating several non-profit and for-profit organizations, serving in the U.S. Air Force in support of 2 foreign wars, and deriving expertise from time spent in industries such as healthcare, financial services, and marketing. He has lived in six countries, traveled to over 30 more, and speaks 3 languages, all which help him view business strategy through the prism of a global, interconnected 21st century. Joseph has a B.S. in Finance from the University of Illinois at Chicago.
Dr. Mitesh B. Rao, MD, MHS, is the System Patient Safety Officer for Stanford Healthcare where he leads Patient Safety for the Enterprise. Dr. Rao also serves as Director of the Center for Advancing Patient Safety (CAPS), which focuses on advancing the science and implementing new innovations in the fields of Patient Safety and Quality Improvement. A Board Certified Emergency Medicine Physician, he practices clinically as an Assistant Professor of Emergency Medicine at the Stanford School of Medicine. Dr. Rao also serves as a mentor to multiple healthcare-focused startups and accelerator groups across the country. Previously, he served as the Director of the Patient Safety Education Program at Northwestern Medicine, where he was helped implement systems-level improvements for quality and safety in institutions across the country and overseas. Dr. Rao was also the Head of Research and Integration for the health innovation program at Northwestern. In this role, he developed an expertise in improving care provision through innovative methodologies.
Cedars-Sinai Health System
Ms. Kristi Ebong, MPH, MBA, is the Director of Health Technology at Cedars-Sinai Health System. She drives progress in digital health and innovation, and is actively involved with the Techstars Healthcare Accelerator in Partnership with Cedars-Sinai. She is also the first female and youngest professional to serve on the board of the Badger Entrepreneurship Forum, a Cali-based group of UW-Madison alumni. Her previous experience includes digital health innovation and health IT at Stanford Health Care; strategy, content development, and market research for Healthspottr’s private network of thought leaders. Kristi holds an MPH and MBA degree from the Johns Hopkins University, and a BA in Global Security/International Studies and Political Science from University of WisconsinMadison.
Marin General Hospital
Dr. John Maa, MD, is a general surgeon at Marin General Hospital. He is also the President Elect of the San Francisco Medical Society. He is a member of the Board of Directors of the American Heart Association and the American College of Surgeons, and is a Past-President of the Northern California Chapter of the American College of Surgeons. He serves as Chair of the University of California, Office of the President Tobacco Related Disease Research Program Scientific Advisory Committee, and as Chair of the American Heart Association Western States Affiliate Advocacy Committee. Previously, Dr. Maa was an assistant professor in general surgery at UCSF. Dr. Maa received his medical degree from Harvard Medical School and completed his general surgical residency at UCSF.
United Negro College Fund
Dr. Chad Womack, PhD, is the National Director of STEM Initiatives at the United Negro College Fund, including the UNCF-Merck Fellowship Program and the co-founder and co-lead of the White House-supported HBCU Innovation, Commercialization & Entrepreneurship. He co-founded The America21 Project and DC Innovates, both innovation-based community and economic development nonprofit organizations dedicated to empowering metro-centers and underserved communities through STEM education, tech-entrepreneurship and access to capital. Dr. Womack also founded the Philadelphia Biotechnology & Life Sciences Institute as a nonprofit initiative dedicated to addressing unmet educational and workforce development needs of Philadelphia. He co-founded 3GEN Vaccines, a nano-biotechnology company. Prior to his entrepreneurial ventures, he completed research fellowships at the NIH, most recently at the National Institutes for Allergy and Infectious Diseases (NIAID) Vaccine Research Center (VRC) and at the Harvard AIDS Institute at the Harvard School of Public Health and the Department of Immunology and Infectious Diseases.
Dr. LaMisha Hill, PhD, joined UCSF in 2014 as the Director of the Multicultural Resource Center. Prior to this, Dr. Hill completed a Post-Doctoral Fellowship at UC Berkeley’s Counseling & Psychological Services, and a Pre-Doctoral Internship at UC Riverside’s Counseling Center. Graduate training in Counseling Psychology from the University of Oregon provided foundations in multicultural and ecological frameworks that further sustain her efforts in diversity and inclusion initiatives in higher education. Dr. Hill is passionate about social justice, advocacy, and equity. She oversees the programmatic efforts of the Multicultural Resource Center, which focus on celebrating diversity, social justice initiatives, and mentorship for historically underrepresented learners.
Building 31 | 310 DNA Way
South San Francisco, CA 94080
Please contact us with any symposium questions.